TY - JOUR
T1 - The HOPES Registry – Houston Methodist Hospital Outcomes-based Prospective Endpoints in Stroke
AU - Gadhia, Rajan
AU - McCane, David
AU - Lee, Jason
AU - Ling, Ken Chyuan
AU - Jiang, Kevin
AU - Chiu, David
PY - 2018/11
Y1 - 2018/11
N2 - Background: We present a single institution registry with the novel feature of 90-day outcome assessments on all hospitalized acute stroke patients, inclusive of every patient with a primary discharge diagnosis of transient ischemic attack (TIA), acute ischemic stroke (AIS), nontraumatic subarachnoid hemorrhage (SAH), and intracerebral hemorrhage (ICH). Methods: Patient data obtained in the HOPES registry include demographics, comorbid diagnoses, medications, health behaviors, laboratory values, imaging studies, vital signs, and outcome measures, most notably the modified Rankin Scale (mRS) at 90 days. Results: From May 2016 to December 31, 2017, 1607 patients were enrolled in the HOPES registry. 90-day outcome assessments were captured on 1555 patients (97%): 1096 AIS, 230 ICH, 110 SAH, and 119 TIA patients. Mortality rates and 90-day outcomes were most favorable for TIA patients. Mortality and 90-day disability scores were poorest for patients in the ICH group. Conclusions: The inclusion of 90-day outcomes data will allow HOPES to stand apart among stroke registries as a new standard for stroke outcomes research. The registry will provide the necessary comprehensive data that the field needs as we transition our focus of stroke research to poststroke recovery.
AB - Background: We present a single institution registry with the novel feature of 90-day outcome assessments on all hospitalized acute stroke patients, inclusive of every patient with a primary discharge diagnosis of transient ischemic attack (TIA), acute ischemic stroke (AIS), nontraumatic subarachnoid hemorrhage (SAH), and intracerebral hemorrhage (ICH). Methods: Patient data obtained in the HOPES registry include demographics, comorbid diagnoses, medications, health behaviors, laboratory values, imaging studies, vital signs, and outcome measures, most notably the modified Rankin Scale (mRS) at 90 days. Results: From May 2016 to December 31, 2017, 1607 patients were enrolled in the HOPES registry. 90-day outcome assessments were captured on 1555 patients (97%): 1096 AIS, 230 ICH, 110 SAH, and 119 TIA patients. Mortality rates and 90-day outcomes were most favorable for TIA patients. Mortality and 90-day disability scores were poorest for patients in the ICH group. Conclusions: The inclusion of 90-day outcomes data will allow HOPES to stand apart among stroke registries as a new standard for stroke outcomes research. The registry will provide the necessary comprehensive data that the field needs as we transition our focus of stroke research to poststroke recovery.
KW - Registry
KW - modified Rankin scale score
KW - outcomes
KW - stroke
UR - http://www.scopus.com/inward/record.url?scp=85050614482&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85050614482&partnerID=8YFLogxK
U2 - 10.1016/j.jstrokecerebrovasdis.2018.06.029
DO - 10.1016/j.jstrokecerebrovasdis.2018.06.029
M3 - Article
C2 - 30072179
AN - SCOPUS:85050614482
SN - 1052-3057
VL - 27
SP - 2973
EP - 2976
JO - Journal of Stroke and Cerebrovascular Diseases
JF - Journal of Stroke and Cerebrovascular Diseases
IS - 11
ER -